Merit Medical Systems, Inc. · NASDAQ:MMSI

Merit Medical Systems — Q1 2016 Earnings Presentation

11 slides from Merit Medical Systems's earnings presentation, Apr 28, 2016

  1. Slide 1: 1st Quarter 2016 Results

    1 1st Quarter 2016 Results FRED LAMPROPOULOS Chairman & CEO BERNARD BIRKETT CFO Exhibit 99.2

  2. Slide 2: Disclosure Regarding Forward-Looking Statements

    2 DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes “forward-looking statements” as defined within applicable securities laws and regulations. All statements in this presentation, other than statements of historical fact, are “forward-looking statements”, including projectio

  3. Slide 3: Financial Summary Non-GAAP

    3 Financial Summary Non-GAAP 2015 2014 Q1 2016 Q1 2015 Revenue (Constant Currency) $553.4M $509.7M $140.0M $129.6M Revenue (Reported) $542.1M $509.7M $138.1M $129.6M Gross Margin 45.6% 46.4% 45.9% 44.9% Net Income $38.5M $33.8M $8.3M $7.9M EPS $0.87 $0.78 $0.19 $0.18

  4. Slide 4: Financial Summary GAAP

    4 Financial Summary GAAP 2015 2014 Q1 2016 Q1 2015 Revenue $542.1M $509.7M $138.1M $129.6M Gross Margin 43.5% 44.2% 43.5% 42.7% Net Income $23.8M $23.0M $4.4M $5.2M EPS $0.53 $0.53 $0.10 $0.12

  5. Slide 5: Sales by Category Q1 2016

    5 Sales by Category Q1 2016 US Direct 47.9% OEM 13.1% Endotek 3.9% International 18.2% EMEA 16.9%

  6. Slide 6: Revenue Growth in Constant Currency

    6 Revenue Growth in Constant Currency -4.0% -2.0% 0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0% 14.0% 16.0% US Direct OEM Endotek International EMEA 12.1% -2.1% 15.8% 15.5% -2.9% Revenue Growth in Constant Currency

  7. Slide 7: Q1 2016 Highlights

    7 Q1 2016 Highlights • Acquired HeRO®Graft product line from CryoLife, Inc. • Approval of Corvocet™ Biopsy System • One-Step™ Centesis line extensions • Canada office and warehouse operational • Mexico facility surpassed break-even point

  8. Slide 8: 2016 Growth Drivers

    8 2016 Growth Drivers • New Products - HeRO® Graft - Corvocet™ Biopsy Device - SwiftNINJA® Steerable Microcatheter - Pedal Access - Micropuncture - Centesis Catheters - Amplatz Guide Wires - 40 ATM BasixTouch™ Inflation Device - Prelude® SNAP Hydrophilic - Wire Guided & Pulmonary Balloons • Wholesal

  9. Slide 9: 2016 Guidance

    9 2016 Guidance Revenues $587M - $597M Gross Margin GAAP 44.5% - 45.5% Gross Margin Non-GAAP 46.5% - 47.5% EPS GAAP $0.74 - $0.80 EPS Non-GAAP $0.97 - $1.03

  10. Slide 10: Disciplined, customer-focused enterprise

    10 1 2 3 4 Disciplined, customer-focused enterprise Guided by strong core values to globally address unmet or underserved healthcare needs Target high-growth, high-return opportunities Through understanding, innovating, and delivering in peripheral, cardiac, OEM, and endoscopy business lines Optimiz

  11. Slide 11: 11

    11

Merit Medical Systems — Q1 2016 Earnings Presentation on 6ix